Drug Trial Radar · NCT01004185
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: May 25, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
39
Actual
Start
Oct 2009
Primary completion
Mar 2011
Study completion Mar 2011
Sponsor
- Lead sponsor
- Warner ChilcottIndustry
- Sponsor type
- Industry
- First posted
- Oct 29, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 5 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether low dose Asacol® (27 mg/kg - 71 mg/kg) and high dose Asacol® (53 mg/kg - 118 mg/kg) are safe and effective when dosed as 400 mg delayed-release tablets given twice daily for 26 weeks to children and adolescents for the maintenance of remission of ulcerative colitis.
Conditions
- Ulcerative Colitis
Interventions
Asacol 400 mgDrug
17-33kg = 3 Asacol 400mg AM \& 2 Asacol 400mg PM; 33-\<54kg = 5 Asacol 400 mg AM \& 4 Asacol 400mg PM; 54-\<90kg = 6 Asacol 400mg AM \& PM
Asacol 400 mgDrug
17-\<33kg = 2 Asacol 400mg \& 1 placebo AM, 1 Asacol 400mg \& 1 placebo PM; 33-\<54kg = 3 Asacol 400mg \& 2 placebo AM, 2 Asacol 400mg \& 2 placebo PM; 54-\<90kg = 3 Asacol 400mg \& 3 placebo AM \& PM
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Success PUCAI (Pediatric Ulcerative Colitis Activity Index), mITT/Modified Intent to Treat PopulationTime frame: Week 26
Locations
51 sites in 6 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Phoenix, Arizona
Research Site
Loma Linda, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
San Francisco, California
Research Site
Gainesville, Florida
Research Site
Miami, Florida
Research Site
Park Ridge, Illinois
Research Site
Louisville, Kentucky
Research Site
Portland, Maine
Research Site
Boston, Massachusetts
Research Site
Worcester, Massachusetts
Research Site
Southfield, Michigan
Research Site
Jackson, Mississippi
Research Site
Kansas City, Missouri
Research Site
Las Vegas, Nevada
Research Site
Mays Landing, New Jersey
Research Site
Buffalo, New York
Research Site
New Hyde Park, New York
Research Site
Providence, Rhode Island
Research Site
Nashville, Tennessee
Research Site
Fort Worth, Texas
Research Site
San Antonio, Texas
Research Site
Huntington, West Virginia
Research Site
Edmonton, Alberta, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Rijeka, Croatia
Research Site
Zagreb, Croatia
Research Site
Bialystok, Poland
Research Site
Bydgoszcz, Poland
Research Site
Katowice, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Warsaw, Poland
Research Site
Wroclaw, Poland
Research Site
Bucharest, Romania
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.